Skip to main content

Table 1 Baseline characteristics of children enrolled for the study

From: Efficacy and safety of the syrup “KalobaTUSS®” as a treatment for cough in children: a randomized, double blind, placebo-controlled clinical trial

  KalobaTUSS® Placebo Whole sample Statistics
Children n. 54 52 106  
Mean age (months) 53.2 ± 11.8 52.9 ± 12.3 53.0 ± 12.0 NS
Median age (months) 52 51.5 52 __
Sex (male/female) 28/26 26/26 54/52 NS
Consecutive days of cough before recruitment 3.53 ± 0.57 3.52 ± 0.58 3.59 ± 0.65 NS
  1. Data are expressed as means ± standard deviation. NS Not significant